Cysteine proteases are the major β-secretase in the regulated secretory pathway that provides most of the β-amyloid in Alzheimer's disease:: Role of BACE 1 in the constitutive secretory pathway

被引:33
作者
Hook, VYH
Reisine, TD
机构
[1] Buck Inst Age Res, Novato, CA 94945 USA
[2] Univ Calif San Diego, Dept Med & Neurosci, San Diego, CA USA
[3] Amer Life Sci Pharmaceut, Mill Valley, CA USA
关键词
Alzheimer's disease; beta-amyloid peptide; A beta regulated secretory pathway; constitutive secretory pathway; cysteine proteases; beta-secretase;
D O I
10.1002/jnr.10784
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This article focuses on beta-amyloid (Abeta) peptide production and secretion in the regulated secretory pathway and how this process relates to accumulation of toxic Abeta in Alzheimer's disease. New findings are presented demonstrating that most of the Abeta is produced and secreted, in an activity-dependent manner, through the regulated secretory pathway in neurons. Only a minor portion of cellular Abeta is secreted via the basal, constitutive secretory pathway. Therefore, regulated secretory vesicles contain the primary beta-secretases that are responsible for producing the majority of secreted Abeta. Investigation of beta-secretase activity in regulated secretory vesicles of neuronal chromaffin cells demonstrated that cysteine proteases account for the majority of the beta-secretase activity. BACE 1 is present in regulated secretory vesicles but provides only a small percentage of the beta-secretase activity. Moreover, the cysteine protease activities prefer to cleave the wild-type beta-secretase site, which is relevant to the majority of AD cases. In contrast, BACE 1 prefers to cleave the Swedish mutant beta-secretase site that is expressed in a minor percentage of the AD population. These new findings lead to a unifying hypothesis in which cysteine proteases are the major beta-secretases for the production of Abeta in the major regulated secretory pathway and BACE 1 is the beta-secretase responsible for Abeta production in the minor constitutive secretory pathway. These results indicate that inhibition of multiple proteases may be needed to decrease Abeta production as a therapeutic strategy for Alzheimer's disease. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:393 / 405
页数:13
相关论文
共 103 条
[81]   Alzheimer's disease: Genes, proteins, and therapy [J].
Selkoe, DJ .
PHYSIOLOGICAL REVIEWS, 2001, 81 (02) :741-766
[82]   Purification and cloning of amyloid precursor protein β-secretase from human brain [J].
Sinha, S ;
Anderson, JP ;
Barbour, R ;
Basi, GS ;
Caccavello, R ;
Davis, D ;
Doan, M ;
Dovey, HF ;
Frigon, N ;
Hong, J ;
Jacobson-Croak, K ;
Jewett, N ;
Keim, P ;
Knops, J ;
Lieberburg, I ;
Power, M ;
Tan, H ;
Tatsuno, G ;
Tung, J ;
Schenk, D ;
Seubert, P ;
Suomensaari, SM ;
Wang, SW ;
Walker, D ;
Zhao, J ;
McConlogue, L ;
John, V .
NATURE, 1999, 402 (6761) :537-540
[83]   Alzheimer's disease: perspectives for the new millennium [J].
Sisodia, SS .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (09) :1169-1170
[84]  
STEINER DF, 1992, J BIOL CHEM, V267, P23435
[85]   THE GENETIC-DEFECT CAUSING FAMILIAL ALZHEIMERS-DISEASE MAPS ON CHROMOSOME-21 [J].
STGEORGEHYSLOP, PH ;
TANZI, RE ;
POLINSKY, RJ ;
HAINES, JL ;
NEE, L ;
WATKINS, PC ;
MYERS, RH ;
FELDMAN, RG ;
POLLEN, D ;
DRACHMAN, D ;
GROWDON, J ;
BRUNI, A ;
FONCIN, JF ;
SALMON, D ;
FROMMELT, P ;
AMADUCCI, L ;
SORBI, S ;
PIACENTINI, S ;
STEWART, GD ;
HOBBS, WJ ;
CONNEALLY, PM ;
GUSELLA, JF .
SCIENCE, 1987, 235 (4791) :885-890
[86]   APOLIPOPROTEIN-E - HIGH-AVIDITY BINDING TO BETA-AMYLOID AND INCREASED FREQUENCY OF TYPE-4 ALLELE IN LATE-ONSET FAMILIAL ALZHEIMER-DISEASE [J].
STRITTMATTER, WJ ;
SAUNDERS, AM ;
SCHMECHEL, D ;
PERICAKVANCE, M ;
ENGHILD, J ;
SALVESEN, GS ;
ROSES, AD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (05) :1977-1981
[87]   Rab3a binding and secretion-enhancing domains in Rim1 are separate and unique - Studies in adrenal chromaffin cells [J].
Sun, L ;
Bittner, MA ;
Holz, RW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) :12911-12917
[88]   THE GENETIC-DEFECT IN FAMILIAL ALZHEIMERS-DISEASE IS NOT TIGHTLY LINKED TO THE AMYLOID BETA-PROTEIN GENE [J].
TANZI, RE ;
STGEORGEHYSLOP, PH ;
HAINES, JL ;
POLINSKY, RJ ;
NEE, L ;
FONCIN, JF ;
NEVE, RL ;
MCCLATCHEY, AI ;
CONNEALLY, PM ;
GUSELLA, JF .
NATURE, 1987, 329 (6135) :156-157
[89]   PROTEASE INHIBITOR DOMAIN ENCODED BY AN AMYLOID PROTEIN-PRECURSOR MESSENGER-RNA ASSOCIATED WITH ALZHEIMERS-DISEASE [J].
TANZI, RE ;
MCCLATCHEY, AI ;
LAMPERTI, ED ;
VILLAKOMAROFF, L ;
GUSELLA, JF ;
NEVE, RL .
NATURE, 1988, 331 (6156) :528-530
[90]  
TANZI RE, 1992, AM J HUM GENET, V51, P273